• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER ORTHOPAEDIC MFG. LTD. FEMUR CEMENTED CRUCIATE RETAINING(CR) NARROW RT SZ; PROSTHESIS, KNEE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER ORTHOPAEDIC MFG. LTD. FEMUR CEMENTED CRUCIATE RETAINING(CR) NARROW RT SZ; PROSTHESIS, KNEE Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Loss of Range of Motion (2032); Scar Tissue (2060)
Date of Event 10/07/2020
Type of Reportable Event Serious Injury
Event or Problem Description
Patient received an initial right total knee arthroplasty.Subsequently, underwent a manipulation, under anesthesia of the right knee two months post procedure, due to arthrofibrosis of the joint.No further complications were reported.Patient demonstrated overall improvement with pain, satisfaction, and quality of life and completed the study per protocol with no further interventions.
 
Additional Manufacturer Narrative
3013876692-2022- code: mechanical (g04) : femur.A manipulation under anesthesia was performed due to according to taber's medical dictionary: manipulation of a joint is a mobilization technique, sometimes involving a rapid thrust or stretching of a joint, with or without anesthesia.With anesthesia is (mua).Per clinical orthopedics and related research (how to treat the stiff total knee arthroplasty? a systematic review), mua is used to treat and resolve arthrofibrosis (scar tissue).This procedure is performed to increase articular motion and reduce chronic pain from arthrofibrosis.The indication for manipulation under anesthesia is related to limited range of motion and stiffness due to adhesions/scar tissue.Additional associated products & mdrs: 42532006402 tibia cemented 5 degree stemmed right size c lot# 64626511 mdr: 3007963827-2022-00142.42522200411 articular surface fixed bearing (uc) right 11 mm lot# 64418973 mdr: 3007963827-2022-00143.00587806529 nexgen complete knee solution, trabecular metal std primary patella lot# 64635672.Mdr: 3005751028-2022-00014.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMUR CEMENTED CRUCIATE RETAINING(CR) NARROW RT SZ
Common Device Name
PROSTHESIS, KNEE
Manufacturer (Section D)
ZIMMER ORTHOPAEDIC MFG. LTD.
building no 2 east park
shannon industrial estate
shannon, county clare
EI 
Manufacturer (Section G)
ZIMMER ORTHOPAEDIC MFG. LTD.
building no 2 east park
shannon industrial estate
shannon, county clare
EI  
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key14496220
Report Number3007963827-2022-00141
Device Sequence Number17592208
Product Code JWH
UDI-Device Identifier00889024229921
UDI-Public(01)00889024229921(17)300131(10)64633161
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
K113369
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number42502006202
Device Lot Number64633161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/28/2022
Initial Report FDA Received Date05/25/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/20/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
Patient Weight74 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-